National Bank Of Canada Sesen Bio, Inc. Transaction History

National Bank Of Canada

  • $72.7 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 13, 2022
SELL
$0.0 - $0.93 $0 - $1,134
-1,220 Reduced 54.95%
1,000 $0
Q4 2021

Jan 24, 2022
BUY
$0.73 - $1.28 $1,620 - $2,841
2,220 New
2,220 $2,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Sesen Bio, Inc.

SESN Quotes by TradingView
  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email